Galentic Pharma India Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 05-07-2024
- Paid Up Capital ₹ 1.34 M
as on 05-07-2024
- Company Age 32 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 115.15 Cr
as on 05-07-2024
- Satisfied Charges ₹ 1.27 Cr
as on 05-07-2024
- Revenue 23.43%
(FY 2022)
- Profit 48.46%
(FY 2022)
- Ebitda -29.32%
(FY 2022)
- Net Worth 18.25%
(FY 2022)
- Total Assets 11.27%
(FY 2022)
About Galentic Pharma India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 1.34 M.
The company currently has active open charges totaling ₹115.15 Cr. The company has closed loans amounting to ₹1.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamlesh Vohra, Bhupendra Sangani, Jay Mehta, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1992PTC065825
- Company No.
065825
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1992
- Date of AGM
13 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Galentic Pharma India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupendra Sangani  | Managing Director | 03-Jan-1994 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manthan Vohra | Director | 26-Sep-2020 | Current |
| Jay Mehta | Director | 26-Sep-2020 | Current |
| Hemang Vohra | Director | 18-Mar-2013 | Current |
| Kamlesh Vohra | Director | 03-Jan-1994 | Current |
| Amisha Gandhi | Director | 28-Sep-2021 | Current |
| Smita Sangani | Director | 18-Mar-2013 | Current |
Financial Performance of Galentic Pharma India.
Galentic Pharma India Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 23.43% increase. The company also saw a substantial improvement in profitability, with a 48.46% increase in profit. The company's net worth Soared by an impressive increase of 18.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Galentic Pharma India?
In 2023, Galentic Pharma India had a promoter holding of 69.63% and a public holding of 30.37%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
The Ethical Pharmaceutical Co. Private LimitedActive 43 years 2 monthsKamlesh Vohra and Bhupendra Sangani are mutual person
Enka Business Technologies LlpActive 9 years 6 monthsKamlesh Vohra and Manthan Vohra are mutual person
- Apollo Business Technologies Private LimitedActive 19 years 4 months
Kamlesh Vohra and Hemang Vohra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 25 Feb 2022 | ₹7.20 Cr | Open |
Citi Bank N.A. Creation Date: 21 Jan 2022 | ₹15.00 Cr | Open |
Hdfc Bank Limited Creation Date: 11 Oct 2013 | ₹11.00 Cr | Open |
How Many Employees Work at Galentic Pharma India?
Galentic Pharma India has a workforce of 267 employees as of Apr 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Galentic Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galentic Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
